Organic Letters · 2015 · 46 citations · 21 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoverySynthetic Medicinal ChemistryPeptide ChemistryPeptide Drug DiscoveryPlatelet ActivationPlatelet AggregationPlatelet FunctionPlatelet PhysiologyAdenosine Diphosphate Receptor BlockadeAdenosine Diphosphate-induced Platelet AggregationOn-resin MacrocyclizationPlatelet Aggregation InhibitionPlatelet Function ModulationPlatelet InhibitionSolid-phase Peptide SynthesisTotal Synthesis-derived Analogues
The first total synthesis of YM-280193, a cyclic depsipeptide that inhibits the ADP-induced aggregation of human platelets, is described. The monomer and dipeptide fragments were prepared using conventional chemistry and subsequently assembled by Fmoc-solid-phase peptide synthesis (Fmoc-SPPS). A late-stage novel bis-alkylation-elimination of cysteine on-resin was employed to introduce the unnatural N-methyldehydroalanine moiety. The final step involved execution of a key macrolactamization reaction between the hindered unnatural N,O-dimethylthreonine and β-hydroxyleucine residues.
21
A Novel Gαq/11-selective Inhibitor
Jun Takasaki, Tetsu Saito, Masatoshi Taniguchi et al. · Journal of Biological Chemistry · 2004 · 411 citations · Full text
Methods for converting cysteine to dehydroalanine on peptides and proteins
Justin M. Chalker, Smita B. Gunnoo, Omar Boutureira et al. · Chemical Science · 2011 · 365 citations